Kuros Biosciences AG
CSBTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $762 | $118 | $60 | $76 |
| - Cash | $17 | $14 | $24 | $29 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $746 | $106 | $38 | $50 |
| Revenue | $76 | $34 | $18 | $14 |
| % Growth | 125.1% | 86.6% | 30.2% | – |
| Gross Profit | $62 | $28 | $11 | $10 |
| % Margin | 82.1% | 84.8% | 59.9% | 72.9% |
| EBITDA | -$1 | -$7 | -$8 | -$5 |
| % Margin | -0.7% | -22.3% | -41.7% | -38.3% |
| Net Income | -$4 | -$14 | -$15 | -$8 |
| % Margin | -4.9% | -40.9% | -81.1% | -54.6% |
| EPS Diluted | -0.1 | -0.38 | -0.43 | -0.23 |
| % Growth | 73.7% | 11.6% | -87% | – |
| Operating Cash Flow | $3 | -$9 | -$7 | -$5 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | $2 | -$9 | -$8 | -$6 |